The E3 ubiquitin ligase MARCH1 regulates antimalaria immunity through interferon signaling and T cell activation is a research paper published in Proceedings of the National Academy of Sciences (2020). On theSindex it has a DataRank of 0. It has been cited 46 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HHS | National Institutes of Health
Grant: Intramural
NCI NIH HHS
Grant: R01 CA101795
NCI NIH HHS
Grant: U54 CA210181
FWCI
2.08
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Targeting UBR5 in hepatocellular carcinoma cells and precise treatment via echinacoside nanodelivery
Additional file 1 of Targeting UBR5 in hepatocellular carcinoma cells and precise treatment via echinacoside nanodelivery
Additional file 1 of MARCH1 negatively regulates TBK1-mTOR signaling pathway by ubiquitinating TBK1
Additional file 1 of MARCH1 negatively regulates TBK1-mTOR signaling pathway by ubiquitinating TBK1